· Single Sales/Supply Contract
KRW 69.2 billion pitavastatin export deal for Southeast Asia with Abbott terminated
A KRW 69.2 billion Southeast Asia pitavastatin export deal with ABBOTT PRODUCTS OPERATIONS AG, disclosed in November 2016, was terminated over weak local business; it took effect February 28, 2024.